CD4 and inflammatory bowel disease: Here, we unravelled that the expression of GPR65 was enhanced in inflamed gut mucosa and PB‐CD4+ T cells of active IBD patients and identified that GPR65 could facilitate Th1 and Th17 cell differentiation and participate in the etiopathogenesis of colitis by impeding NUAK2 expression.